- Article
Identification of Novel Trypanosoma cruzi Cysteine Protease Inhibitors via Ligand-Based Virtual Screening of FDA-Approved Drugs with Trypanocidal Activity
- Lenci K. Vázquez-Jiménez,
- Alonzo González-González,
- Timoteo Delgado-Maldonado,
- Rogelio Gómez-Escobedo,
- Benjamín Nogueda-Torres,
- Ana Verónica Martínez-Vázquez,
- Eyrá Ortiz-Pérez,
- Charmina Aguirre-Alvarado,
- Verónica Alcántara-Farfán and
- Gildardo Rivera
- + 3 authors
Background: Chagas disease is a major public health problem, especially in Latin American countries, and benznidazole and nifurtimox are currently the only drugs available for its treatment. However, they present several disadvantages, such as low av...

